MYLAN IRELAND LTD. – Trademark Portfolio

Entity Type: 11

MYLAN IRELAND LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include X and ARIXTRA. The owner is based in DUBLIN.

SOUTH BANK HOUSE, BARROW STREET, 6TH

FLOOR

DUBLIN 4 , IE

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

X
X
Registered 2001
ARIXTRA
ARIXTRA
Registered 2001
ARIXTRA
ARIXTRA
Registered 1999

Trademark Classifications

MYLAN IRELAND LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MYLAN IRELAND LTD. have?

MYLAN IRELAND LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does MYLAN IRELAND LTD. file in?

MYLAN IRELAND LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MYLAN IRELAND LTD.'s most well-known trademarks?

MYLAN IRELAND LTD.'s registered trademark portfolio includes well-known marks such as X and ARIXTRA. These are among 3 currently registered trademarks in the portfolio.

What is MYLAN IRELAND LTD.'s trademark registration success rate?

MYLAN IRELAND LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.